US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      THOMAS BUILT BUSES ( 22V441000 )

      Dated: JUN 22, 2022 Daimler Trucks North America, LLC (DTNA) is recalling certain 2023 Thomas Built Saf-T-Liner C2 School Buses. The buses may not … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Medicis Announces Recall of Solodyn (minocycline HCL, USP) Tablets Over Product Mix-Up

Medicis Announces Recall of Solodyn (minocycline HCL, USP) Tablets Over Product Mix-Up

May 20, 2008 By The FDA Leave a Comment

CONTACT: STERICYCLE CUSTOMER SERVICE 1-888-656-6381

FOR IMMEDIATE RELEASE — SCOTTSDALE, ARIZ. — MAY 16, 2008 — MEDICIS TODAY ANNOUNCED THAT THE COMPANY IS VOLUNTARILY RECALLING LOT NUMBERS B080037 (EXP: 12/09) AND B080038 (EXP: 12/09) OF THE ANTIBIOTIC SOLODYN® (MINOCYCLINE HCL, USP) EXTENDED RELEASE TABLETS, 90 MG, 30-COUNT BOTTLES (NDC 99207-461-30). MEDICIS HAS RECEIVED A REPORT THAT ONE BOTTLE IN LOT NUMBER B080037 CONTAINS AZASAN® (AZATHIOPRINE TABLETS) 75 MG (NDC 65649-231-51) INSTEAD OF SOLODYN® (MINOCYCLINE HCL, USP) EXTENDED RELEASE TABLETS, 90 MG. AZASAN® IS AN IMMUNO-SUPPRESSIVE AGENT USED IN TRANSPLANT PATIENTS TO PREVENT KIDNEY REJECTION AND FOR THE TREATMENT OF RHEUMATOID ARTHRITIS. TAKING AZASAN® INSTEAD OF SOLODYN® PRESENTS A HEALTH HAZARD AND SAFETY RISK TO PATIENTS. SIDE EFFECTS ASSOCIATED WITH THE USE OF AZASAN®, PARTICULARLY IN THE ELDERLY, INCLUDE MYLOSUPPRESSION (DECREASE IN THE NUMBER OF RED AND WHITE BLOOD CELLS AND PLATELETS), INFECTION, BLEEDING, CHILLS, NAUSEA, VOMITING AND DIARRHEA. JOINT AND MUSCLE PAIN ARE ALSO COMMON SIDE EFFECTS. UNANTICIPATED INTERACTIONS WITH OTHER DRUGS MAY ALSO LEAD TO SERIOUS ADVERSE EVENTS. SOLODYN® IS MANUFACTURED BY AAIPHARMA, INC. UNDER CONTRACT TO MEDICIS. THE TWO LOTS WERE MANUFACTURED DURING FEBRUARY 2008. THE RECALL IS LIMITED TO THESE LOTS, AND AMPLE SUPPLIES OF SOLODYN® REMAIN ON THE MARKET.

ANY INQUIRIES RELATED TO THIS RECALL SHOULD BE ADDRESSED TO STERICYCLE CUSTOMER SERVICE AT 1-888-656-6381 WITH REPRESENTATIVES AVAILABLE MONDAY THROUGH FRIDAY, 8 A.M. TO 11 P.M. EST. FOR ANY MEDICAL INFORMATION INQUIRIES OR TO REPORT AN ADVERSE EVENT RELATED TO THIS RECALL, CONTACT MEDICIS AT 1-800-900-6389 WITH REPRESENTATIVES AVAILABLE 24 HOURS A DAY, 7 DAYS A WEEK.

HEALTH CARE PROFESSIONALS MAY CONTINUE TO PRESCRIBE THE MEDICIS BRAND SOLODYN®.

THIS RECALL IS BEING CONDUCTED IN COOPERATION WITH THE CONTRACT MANUFACTURER OF THE PRODUCTS AND WITH THE KNOWLEDGE OF THE FDA.

ANY ADVERSE REACTIONS EXPERIENCED WITH THE USE OF THIS PRODUCT, AND/OR QUALITY PROBLEMS, ALSO MAY BE REPORTED TO THE FDA’S MEDWATCH PROGRAM BY PHONE AT 1-800-FDA-1088, BY FAX AT 1-800-FDA-0178, BY MAIL AT MEDWATCH, FDA, 5600 FISHERS LANE, ROCKVILLE, MD 20852-9787, OR ON THE MEDWATCH WEBSITE AT WWW.FDA.GOV/MEDWATCH.

SOLODYN IS A REGISTERED TRADEMARK OF MEDICIS PHARMACEUTICAL CORPORATION. AZASAN IS A REGISTERED TRADEMARK OF AAIPHARMA, INC.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

THOMAS BUILT BUSES ( 22V441000 )

June 28, 2022 By NHTSA

THOMAS BUILT BUSES ( 22V438000 )

June 28, 2022 By NHTSA

NISSAN ( 22V420000 )

June 28, 2022 By NHTSA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

KENTUCKY TRAILER ( 22V419000 )

June 25, 2022 By NHTSA

KAUFMAN ( 22V421000 )

June 25, 2022 By NHTSA

TOYOTA ( 22V444000 )

June 24, 2022 By NHTSA

NOVA BUS ( 22V416000 )

June 24, 2022 By NHTSA

CRUISER RV ( 22V433000 )

June 24, 2022 By NHTSA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

NOVA BUS ( 22V416000 )

June 24, 2022 By NHTSA

CRUISER RV ( 22V433000 )

June 24, 2022 By NHTSA

UTILIMASTER ( 22V417000 )

June 24, 2022 By NHTSA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • THOMAS BUILT BUSES ( 22V441000 )
  • THOMAS BUILT BUSES ( 22V438000 )
  • NISSAN ( 22V420000 )
  • FCCC ( 22V439000 )
  • URAL ( 22V431000 )
  • KENTUCKY TRAILER ( 22V419000 )
  • KAUFMAN ( 22V421000 )
  • TOYOTA ( 22V444000 )
  • NOVA BUS ( 22V416000 )
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2022 Altrumedia · Terms of Service · Log in